Xenon Pharmaceuticals XENE Unveils Robust Azetukalner Phase III Data Q3 NDA Filing Plans at Bloom Burton Conference BLNK Blink reports far wider Q4 2025 loss than estimates even as shares tick marginally higher Would buying Hall HCACR stock now make sense HCACR Latest Quarter Earnings Hall discloses no financials as it pursues deSPAC targets